Abstract
Anoro Ellipta is the first inhaler to combine a LAMA and a LABA in a single unit. Here we present the clinical data relating to its efficacy and adverse events and look at its place in the management of COPD.
Cite
CITATION STYLE
APA
Chaplin, S. (2015). Anoro Ellipta: dry powder LAMA/LABA combination for COPD. Prescriber, 26(4), 12–14. https://doi.org/10.1002/psb.1308
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free